"
Template:SupbiotechparisFr
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| (3 intermediate revisions not shown) | |||
| Line 7: | Line 7: | ||
<a href="https://2009.igem.org/Team:SupBiotech-Paris/HomeFr#drapeau" target="_self"> | <a href="https://2009.igem.org/Team:SupBiotech-Paris/HomeFr#drapeau" target="_self"> | ||
<img title="Wiki en français." style="margin: 10px 0px 10px 0px; width: 30px;" src="https://static.igem.org/mediawiki/2009/a/ad/DrapeauFrance.png";> | <img title="Wiki en français." style="margin: 10px 0px 10px 0px; width: 30px;" src="https://static.igem.org/mediawiki/2009/a/ad/DrapeauFrance.png";> | ||
| - | |||
| - | |||
| - | |||
</a> | </a> | ||
</div> | </div> | ||
| Line 20: | Line 17: | ||
<html> | <html> | ||
<div id="logosb" style="float: left;"> | <div id="logosb" style="float: left;"> | ||
| - | <a href="http://www.supbiotech. | + | <a href="http://www.supbiotech.fr" target="_blank"> |
| - | <img title="www.supbiotech. | + | <img title="www.supbiotech.fr" style="width: 80px;" src="https://static.igem.org/mediawiki/2009/9/91/Logosupbiotech.jpg";> |
</a> | </a> | ||
</div> | </div> | ||
| Line 76: | Line 73: | ||
<div id="Partie" style="color: white; font-weight: bold; margin-bottom: -7px;">Ressources</div> | <div id="Partie" style="color: white; font-weight: bold; margin-bottom: -7px;">Ressources</div> | ||
| - | [[Team:SupBiotech-Paris/BiobricksFr#drapeau| | + | [[Team:SupBiotech-Paris/BiobricksFr#drapeau|BioBricks]] |
[[Team:SupBiotech-Paris/Matériel & Méthode#drapeau|Matériel & Méthode]] | [[Team:SupBiotech-Paris/Matériel & Méthode#drapeau|Matériel & Méthode]] | ||
[[Team:SupBiotech-Paris/Bibliographie#drapeau|Bibliographie]] | [[Team:SupBiotech-Paris/Bibliographie#drapeau|Bibliographie]] | ||
Latest revision as of 23:56, 21 October 2009
Projet
Introduction Thérapies actuelles Thérapies géniques Le DVS Concept Vecteur Tissulaire Vecteur Cellulaire Plasmide thérapeutique Conclusion Mise en application Ciblage Tissulaire Action antitumorale Modeling du traitement Conclusion
Ressources
BioBricks Matériel & Méthode Bibliographie
Ethique & sûreté
